Results 121 to 130 of about 55,751 (154)
Safety, tolerability, and immunogenicity of a new SARS-CoV-2 recombinant Gamma variant RBD-based protein adjuvanted vaccine, used as heterologous booster in healthy adults: a Phase 1 interim report
, 2023 Pasquevich KA, Coria LM, Ceballos A, Mazzitelli B, Rodriguez JM, Demaría A, Castro CP, Bruno L, Saposnik L, Salvatori M, Varese A, González S, González Martínez VV, Geffner J, Álvarez D, Laboratorio Pablo Cassará R&D and CMC group for ARVAC-CG, Feleder E, Halabe K, Perez Lera PE, de Oca FM, Vega JC, Lombardo M, Yerino GA, Fló J, Cassataro J. +24 moreeuropepmc +1 more sourceExploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults. [PDF]
Am J Respir Crit Care MedPerez-de-Llano L, Scelo G, Tran TN, Le TT, Fagerås M, Cosio BG, Peters M, Pfeffer PE, Al-Ahmad M, Al-Lehebi RO, Altraja A, Bergeron C, Bjermer LH, Bjerrum AS, Bulathsinhala L, Busby J, Cano Rosales DJ, Canonica GW, Carter VA, Charriot J, Christoff GC, Denton EJ, Dorscheid DR, Fernandez Sanchez MJ, Fonseca JA, Gibson PG, Goh CYY, Heaney LG, Heffler E, Hew M, Iwanaga T, Katial R, Koh MS, Kuna P, Larenas-Linnemann DES, Lehtimäki L, Mahboub B, Martin N, Matsumoto H, Menzies-Gow AN, Papadopoulos NG, Popov TA, Porsbjerg CM, Patel P, Rhee CK, Sadatsafavi M, Taillé C, Torres-Duque CA, Tsai MJ, Ulrik CS, Upham JW, von Bülow A, Wang E, Wechsler ME, Price DB. +54 moreeuropepmc +1 more sourceBiomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR). [PDF]
World Allergy Organ JSchleich F, Larenas-Linnemann D, Altraja A, Pérez de Llano L, Kostikas K, Sadatsafavi M, Bourdin A, Alton Pleasants R, Hew M, Chen W, Jiménez-Maldonado L, Couillard S, Suppli Ulrik C, Bulkhi AA, Tsai MJ, Christoff GC, Papadopoulos NG, Pfeffer PE, Ryan D, Bergeron C, Al-Ahmad MS, Dorscheid DR, Wang E, Blakey JD, Cochrane B, Peters MJ, Popov TA, Torres-Duque CA, Hansen S, Puggioni F, Fletton K, Salameh L, Middleton PG, Márcio Pitrez P, Kook Rhee C, Denton E, Chapman KR, Lehtimäki L, Murray RB, Sheu CC, Jackson DJ, Al-Lehebi R, Siyue Koh M, Mahboub B, Ardusso LRF, Gogali A, Canonica GW, Kuna P, Sivori M, Louis R, Abercromby S, Guida G, Aarli BB, Beastall A, Carter V, Scelo G, Townend J, Cosio BG, Patel PH, Goh CYY, Csoma Z, Upham JW, Fonseca JA, Gibson PG, Jenkins C, Brusselle GG, Chèvremont A, Côté A, Celis-Preciado CA, Solarte I, Porsbjerg CM, Sverrild A, Kauppi P, Loukides S, Makris MP, Papaioannou AI, Heffler E, Chan JSK, Joo H, Heaney LG, Cheng WH, Lugogo N, Wechsler ME, Chaves Loureiro C, Rodríguez-Cáceres B, Nagano T, Wang Z, Wang HC, Máspero J, Saldarini F, Stok AM, Yañez A, Bardin PG, Bosnic-Anticevich SZ, Navaratnam V, Bhutani M, Lougheed MD, Melenka L, Bakakos P, Exarchos KP, Ladias AA, Lúdvíksdóttir D, Iwanaga T, Contreras Contreras EA, Lehmann S, Ferreira JA, Gall R, Fu PK, Perng DW, Hoyte F, Katial R, Björnsdóttir US, Taillé C, Taube C, Cushen B, Bulathsinhala L, Bjermer L, Price DB, ISAR STAR Working Group. +118 moreeuropepmc +1 more source
